½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1301129

ûÁø±â ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : ±â¼ú À¯Çüº°(ÀüÀÚ/µðÁöÅÐ, ½º¸¶Æ®, ½º¸¶Æ®, ±âÁ¸ À½Çâ ûÁø±â), ÆǸŠä³Îº°(ÆǸŠ´ë¸®Á¡, E-Commerce, Á÷Á¢ ±¸¸Å), ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°(2023-2030³â)

Stethoscope Market Size, Share & Trends Analysis Report By Technology Type (Electronic/Digital, Smart, Traditional Acoustic Stethoscope), By Sales Channel (Distributors, E-commerce, Direct Purchase), By End Use, And By Region, 2023 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 168 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ûÁø±â ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¼¼°èÀÇ Ã»Áø±â ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 9¾ï 4,988¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¶ÇÇÑ 2023-2030³â 5.9%ÀÇ CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ½ÉÇ÷°ü ¹× ÆóÁúȯÀÇ ÀÌȯÀ² Áõ°¡¿Í ÀÌ·¯ÇÑ ¸¸¼ºÁúȯÀÇ Áø´Ü¿¡¼­ µðÁöÅРûÁø±âÀÇ Àû¿ë Áõ°¡´Â ¿¹Ãø ±â°£ Áß ÀÌ·¯ÇÑ ÀåºñÀÇ Ã¤ÅÃÀ» Å©°Ô ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¶ÇÇÑ 2020³â COVID-19ÀÇ À¯ÇàÀº ¼¼°è¿¡¼­ ûÁø±â »ç¿ëÀ» Å©°Ô Áõ°¡½ÃÄ×À¸¸ç, COVID-19´Â ¸Å¿ì Àü¿°¼ºÀÌ °­ÇÑ È£Èí±â ÁúȯÀ̱⠶§¹®¿¡ ¸ðµç ÀÓ»ó ÇöÀå¿¡¼­ Æó¿Í ½ÉÀåÀÇ ¼Ò¸®¸¦ µè´Â Ãʱâ Áø´ÜÀÌ °¡Àå Áß¿äÇÕ´Ï´Ù. µû¶ó¼­ ÆÒµ¥¹ÍÀÌ Á¾½ÄµÈ ÀÌÈÄ¿¡µµ ½ÃÀåÀº Áö¼ÓÀûÀ¸·Î Å« ÆøÀ¸·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¤ºÎ ±¸»óÀÇ Ãâ¹ü, ½ÅÁ¦Ç° Ãâ½Ã, ½ÃÀå ÁøÃâ±â¾÷ÀÇ ½Å±â¼ú µµÀÔÀº ¿¹Ãø ±â°£ Áß ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î 3MÀº ÀÏȸ¿ë ûÁø±â¸¦ »ç¿ëÇÒ ¶§ ¹ß»ýÇÏ´Â ºÒÃæºÐÇÑ Ã»ÁøÀ½°ú ÀÇ·á Àü¹®°¡°¡ ´À³¢´Â ºÒÆíÇÔÀ» ±Øº¹Çϱâ À§ÇØ '´ÜÀÏ È¯ÀÚ Ã»Áø±â'¸¦ Ãâ½ÃÇß½À´Ï´Ù. ¶ÇÇÑ ÀΰøÁö´É(AI)À» »ç¿ëÇÏ¿© ³ìÀ½ÇÏ°í ±× ³ìÀ½À» °¡»óÀ¸·Î Àǻ翡°Ô Àü¼ÛÇÏ´Â µðÁöÅÐ/½º¸¶Æ® ûÁø±â¸¦ Ãâ½ÃÇÏ¿© Àǻ簡 »çȸÀû °Å¸®¸¦ À¯ÁöÇÏ°í COVID-19¿¡ ³ëÃâµÉ ±âȸ¸¦ ÁÙÀÏ ¼ö ÀÖµµ·Ï Çß½À´Ï´Ù.

ûÁø±â ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • ±â¼úº°·Î´Â ÀüÅëÀûÀÎ À½Çâ ûÁø±â ºÐ¾ß°¡ 2022³â 74.35%ÀÇ Á¡À¯À²À» Â÷ÁöÇϸç Àüü ½ÃÀåÀ» Áö¹èÇß½À´Ï´Ù.
  • ÆǸŠä³Îº°·Î´Â ´ë¸®Á¡ ½ÃÀåÀÌ 2022³â 54.28%ÀÇ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ´Â º´¿ø ¹× Áø·á¼Ò°¡ ÀϹÝÀûÀ¸·Î ´ë¸®Á¡ ¹× Á¦Á¶¾÷ü¿Í Àå±âÀûÀÎ °è¾à ¹× Á¦ÈÞ¸¦ ¸Î¾î À§Å¹ ºñ¿ë ¹× ±âŸ ¹è¼Û ºñ¿ëÀ» Àý°¨ÇÒ ¼ö Àֱ⠶§¹®ÀÔ´Ï´Ù.
  • º´¿øÀº 2022³â 40.75%ÀÇ ÃÖ´ë Á¡À¯À²·Î ÃÖÁ¾ ¿ëµµ ºÎ¹®À» µ¶Á¡ÇÏ°í ¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº CAGR·Î ¹ßÀüÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • ºÏ¹Ì´Â Àß ±¸ÃàµÈ ÀÇ·á ½Ã¼³ÀÇ Á¸Àç¿Í ½ÉÀå ¹× Æó °ü·Ã ÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ 2022³â 32.85%ÀÇ °¡Àå ³ôÀº ¸ÅÃâ Á¡À¯À²·Î Áö¿ª ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

  • ½ÃÀå ¼¼ºÐÈ­¿Í ¹üÀ§
    • Å×Å©³î·¯ÁöÀÇ À¯Çü
    • ÆǸŠä³Î
    • ÃÖÁ¾ ¿ëµµ
    • ÃßÁ¤¡¤¿¹Ãø ŸÀÓ¶óÀÎ
  • Á¶»ç ¹æ¹ý
  • Á¤º¸ Á¶´Þ
    • ±¸ÀÔÇÑ µ¥ÀÌÅͺ£À̽º :
    • GvrÀÇ ³»ºÎ µ¥ÀÌÅͺ£À̽º
    • 2Â÷ Á¤º¸
    • 1Â÷ Á¶»ç
    • 1Â÷ Á¶»ç »ó¼¼
  • Á¤º¸ ¶Ç´Â µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ ºÐ¼® ¸ðµ¨
  • ½ÃÀå Çü¼º°ú °ËÁõ
  • ¸ðµ¨ »ó¼¼
    • »óÇ° Ç÷οì Çؼ®(¸ðµ¨ 1)
    • ¼ö·® °¡°Ý ºÐ¼®(¸ðµ¨ 2)
  • 2Â÷ Á¤º¸ ¸®½ºÆ®
  • 1Â÷ Á¤º¸ ¸®½ºÆ®
  • ¾à¾î ¸®½ºÆ®
  • ¸ñÀû

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå Àü¸Á
  • ºÎ¹® Àü¸Á
  • °æÀï ÀλçÀÌÆ®

Á¦3Àå ûÁø±â ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • ¸ð½ÃÀå Àü¸Á
    • ºÎ¼öÀûÀÎ ½ÃÀå Àü¸Á
  • º¸±Þ°ú ¼ºÀå Àü¸Á ¸ÅÇÎ
  • ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
  • Á¦Ç° ÆÄÀÌÇÁ¶óÀÎ ºÐ¼®
  • Á¦Ç° ÆÄÀÌÇÁ¶óÀÎ ºÐ¼®
  • ¼ÒºñÀÚ Çൿ ºÐ¼®
    • ½ÃÀå ¿µÇâ·Â ºÐ¼®
    • ÀÇ»çÀÇ ¿µÇâ
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ûÁø±â : ½ÃÀå ºÐ¼® Åø
    • ¾÷°è ºÐ¼® : PorterÀÇ »ê¾÷ ºÐ¼®
    • SWOT ºÐ¼®, PESTº°
  • ûÁø±â : COVID-19ÀÇ ¿µÇâ
    • º¯È­ÇÏ´Â ½ÃÀå µ¿Çâ
    • °ø±Þ/¹°·ù¿¡ ´ëÇÑ ¿µÇâ
  • ½ÃÀå Âü¿© Àü·«
    • Çõ½Å /OEM
    • Áö¿ªÀû È®´ë
    • Á¦Ç° ¹ß¸Å
    • ¹ÌÃæÁ· ¿ä±¸ÀÇ °³Ã´

Á¦4Àå ûÁø±â ½ÃÀå : Å×Å©³î·¯Áöº° ºÎ¹® ºÐ¼®, 2018-2030³â(100¸¸ ´Þ·¯)

  • Á¤ÀÇ¿Í ¹üÀ§
  • Å×Å©³î·¯Áö ½ÃÀå Á¡À¯À² ºÐ¼®, 2022³â ¹× 2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ûÁø±â ½ÃÀå, Å×Å©³î·¯Áöº°, 2018-2030³â
  • ½ÃÀå ±Ô¸ð, ¿¹Ãø, µ¿Ç⠺м®, 2018-2030³â
    • ÀüÀÚ/µðÁöÅРûÁø±â
    • ½º¸¶Æ® ûÁø±â
    • ±âÁ¸ À½Çâ ûÁø±â

Á¦5Àå ûÁø±â ½ÃÀå : ÆǸÅä³Îº° ºÎ¹® ºÐ¼®, 2018-2030³â(100¸¸ ´Þ·¯)

  • Á¤ÀÇ¿Í ¹üÀ§
  • ä³Î ½ÃÀå Á¡À¯À² ºÐ¼®, 2022³â ¹× 2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ûÁø±â ½ÃÀå, ä³Îº°, 2018-2030³â
  • ½ÃÀå ±Ô¸ð, ¿¹Ãø, ¾ç ¹× µ¿Ç⠺м®, 2020-2028³â
  • ÆǸŠ´ë¸®Á¡
    • ÆǸŠ´ë¸®Á¡ ½ÃÀå, 2018-2030³â(100¸¸ ´Þ·¯)
    • E-Commerce
    • Á÷Á¢ ±¸ÀÔ

Á¦6Àå ûÁø±â ½ÃÀå : ÃÖÁ¾ ¿ëµµº° ºÎ¹® ºÐ¼®, 2018-2030³â(100¸¸ ´Þ·¯)

  • Á¤ÀÇ¿Í ¹üÀ§
  • ÃÖÁ¾ ¿ëµµ ½ÃÀå Á¡À¯À² ºÐ¼®, 2022³â ¹× 2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ûÁø±â ½ÃÀå, ÃÖÁ¾ ¿ëµµº°, 2018-2030³â
  • ½ÃÀå ±Ô¸ð, ¿¹Ãø, ¾ç ¹× µ¿Ç⠺м®, 2018-2030³â
  • ȨÇコÄɾî
    • ȨÇコÄÉ¾î ½ÃÀå, 2018-2030³â(100¸¸ ´Þ·¯)
    • º´¿ø
    • Ŭ¸®´Ð
    • °£È£»ç
    • ±¸±Þ´ë¿ø/ÆÛ½ºÆ® ¸®½ºÆù´õ
    • ¼öÀÇ

Á¦7Àå ûÁø±â ½ÃÀå : Áö¿ª ½ÃÀå ºÐ¼®, ±â¼ú À¯Çüº°, ÆǸÅä³Îº°, ÃÖÁ¾ ¿ëµµº°, 2018-2030³â(100¸¸ ´Þ·¯, ´ÜÀ§)

  • Á¤ÀÇ¿Í ¹üÀ§
  • Áö¿ª ½ÃÀå Á¡À¯À² ºÐ¼®, 2022³â ¹× 2030³â
  • Áö¿ª ½ÃÀå ½º³À¼ô
  • ½ÃÀå ±Ô¸ð, ¿¹Ãø, µ¿Ç⠺м®, 2022³â°ú 2030³â
  • ºÏ¹Ì
    • ºÏ¹ÌÀÇ Ã»Áø±â ½ÃÀå, 2018-2030(100¸¸ ´Þ·¯, ´ÜÀ§)
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • À¯·´ÀÇ Ã»Áø±â ½ÃÀå, 2018-2030(100¸¸ ´Þ·¯, ´ÜÀ§)
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • µ§¸¶Å©
    • ½º¿þµ§
    • ³ë¸£¿þÀÌ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ã»Áø±â ½ÃÀå, 2018-2030³â(100¸¸ ´Þ·¯, ´ÜÀ§)
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • ű¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ Ã»Áø±â ½ÃÀå, 2018-2030(100¸¸ ´Þ·¯, ´ÜÀ§)
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîƼ³ª
  • MEA
    • MEAÀÇ Ã»Áø±â ½ÃÀå, 2018-2030³â(100¸¸ ´Þ·¯, ´ÜÀ§)
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • Äí¿þÀÌÆ®

Á¦8Àå ûÁø±â ½ÃÀå - °æÀï ºÐ¼®

  • ±â¾÷ Á¡À¯À² ºÐ¼®, 2021³â
  • Á¦Ç°/ºê·£µåÀÇ ºñ±³ ºÐ¼®
  • ÁÖ¿ä ÆǸŠ´ë¸®Á¡ ¸®½ºÆ®
    • ºÏ¹Ì
    • À¯·´
    • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ±â¾÷ °³¿ä
    • Eko Devices Inc.
    • 3m
    • Medline Industries Inc.
    • Heine Optotechnik Gmbh &Co. Kg
    • Welch Allyn(Hill-Rom Holdings, Inc.)
    • Gf Health Products, Inc.
    • Rudolf Riester Gmbh
    • American Diagnostics Corporation
    • Cardionics
    • Heine Optotechnik Gmbh &Co. Kg
KSA 23.07.24

Stethoscope Market Growth & Trends

The global stethoscope market size is anticipated to reach USD 949.88 million by 2030, according to a new report by Grand View Research, Inc. Furthermore, the report forecasts the industry to expand at a CAGR of 5.9% from 2023 to 2030. The increasing incidences of cardiovascular & pulmonary diseases, along with the growing application of digital stethoscopes in the diagnosis of such chronic conditions, are expected to boost the adoption of these devices significantly during the forecast period.

In addition, the outbreak of the COVID-19 pandemic in the year 2020 significantly boosted the use of stethoscopes globally. Since COVID-19 is extremely infectious and a respiratory ailment, initial diagnosis by listening to the lungs and heart is of the utmost importance in any clinical setting. Thus, the market is expected to witness substantial and continuous growth even after the end of the pandemic.

The launch of several government initiatives, the introduction of new products, and the incorporation of new technologies by market players are expected to propel the market during the projection period. For instance, 3M has launched the 'Single-Patient Stethoscope' to overcome the issues faced while using disposable stethoscopes, such as inadequate audibility & discomfort for healthcare professionals. Also, the launch of digital/smart stethoscope that uses Artificial Intelligence (AI) to record and send recordings to physicians virtually allows them to maintain social distancing and reduce exposure to COVID-19.

Stethoscope Market Report Highlights

  • Based on technology, the traditional acoustic stethoscope segment dominated the overall market with a share of 74.35% in 2022, since it is comparatively inexpensive, simple to use, and widely available for use for paramedics & nurses
  • Based on the sales channel, the distributors' segment dominated the market with a share of 54.28% in 2022. This is because hospitals & clinics usually have long-term contracts and tie-ups with distributors & manufacturers, which helps save on consignment and other delivery costs
  • Hospitals dominated the end-use segment with the largest share of 40.75% in 2022, and the segment is further expected to advance at the highest CAGR during the forecast period
  • North America dominated the regional market with the highest revenue share of 32.85% in 2022, owing to the presence of well-established healthcare facilities and the increasing prevalence of heart- and lung- associated diseases

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation And Scope
    • 1.1.1 Technology Type
    • 1.1.2 Sales Channel
    • 1.1.3 End Use
    • 1.1.4 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database:
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
      • 1.6.1.1 Approach 1: Commodity Flow Approach
    • 1.6.2 Volume Price Analysis (Model 2)
      • 1.6.2.1 Approach 2: Volume Price Analysis
  • 1.7 List Of Secondary Sources
  • 1.8 List Of Primary Sources
  • 1.9 List Of Abbreviations
  • 1.10 Objectives

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
  • 2.3 Competitive Insights

Chapter 3 Stethoscope Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Regulatory Framework
  • 3.4 Product Pipeline Analysis
  • 3.5 Product Pipeline Analysis
  • 3.6 Consumer Behavior Analysis
    • 3.6.1 Market Influencer Analysis
    • 3.6.2 Physician Influence
      • 3.6.2.1 Reasons For Upgrade To Stethoscope
      • 3.6.2.2 Lifespan/Average Turnover Time To Upgrade From Traditional Stethoscope
  • 3.7 Market Dynamics
    • 3.7.1 Market Driver Analysis
      • 3.7.1.1 Rising Prevalence Of Cardiovascular And Respiratory Diseases
      • 3.7.1.2 Increase In Geriatric Population
      • 3.7.1.3 Increasing Application Of Digital Stethoscope In Diagnosis Of Chronic Conditions
    • 3.7.2 Market Restraints Analysis
      • 3.7.2.1 High Cost Of Electronic/Smart Stethoscopes
  • 3.8 Stethoscope: Market Analysis Tools
    • 3.8.1 Industry Analysis - Porter's
    • 3.8.2 Swot Analysis, By Pest
  • 3.9 Stethoscope: Covid-19 Impact
    • 3.9.1 Changing Market Trends
    • 3.9.2 Supply/Logistics Impact
  • 3.10 Market Entry Strategies
    • 3.10.1 Innovation/Oem
    • 3.10.2 Geographic Expansion
    • 3.10.3 Product Launches
    • 3.10.4 Tapping Unmet Needs

Chapter 4 Stethoscope Market: Segment Analysis, By Technology, 2018 - 2030 (USD Million)

  • 4.1 Definition And Scope
  • 4.2 Technology Market Share Analysis, 2022 & 2030
  • 4.3 Segment Dashboard
  • 4.4 Stethoscope Market, By Technology, 2018 To 2030
  • 4.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
    • 4.5.1 Electronic/Digital Stethoscope
      • 4.5.1.1 Electronic/Digital Stethoscope Market, 2018 - 2030 (USD Million)
    • 4.5.2 Smart Stethoscope
      • 4.5.2.1 Smart Stethoscope Market, 2018 - 2030 (USD Million)
    • 4.5.3 Traditional Acoustic Stethoscope
      • 4.5.3.1 Traditional Acoustic Stethoscope Market, 2018 - 2030 (USD Million)

Chapter 5 Stethoscope Market: Segment Analysis, By Sales Channel, 2018 - 2030 (USD Million)

  • 5.1 Definition & Scope
  • 5.2 Channel Market Share Analysis, 2022 & 2030
  • 5.3 Segment Dashboard
  • 5.4 Stethoscope Market, By Channel, 2018 To 2030
  • 5.5 Market Size, & Forecasts, Volume And Trend Analysis, 2020 To 2028
  • 5.6 Distributors
    • 5.6.1 Distributors Market, 2018 - 2030 (USD Million)
    • 5.6.2 E-Commerce
      • 5.6.2.1 E-Commerce Market, 2018 - 2030 (USD Million)
    • 5.6.3 Direct Purchase
      • 5.6.3.1 Direct Purchase Market, 2018 - 2030 (USD Million)

Chapter 6 Stethoscope Market: Segment Analysis, By End Use, 2018 - 2030 (USD Million)

  • 6.1 Definition & Scope
  • 6.2 End-Use Market Share Analysis, 2022 & 2030
  • 6.3 Segment Dashboard
  • 6.4 Stethoscope Market, By End Use, 2018 To 2030
  • 6.5 Market Size, & Forecasts, Volume And Trend Analysis, 2018 To 2030
  • 6.6 Home Healthcare
    • 6.6.1 Home Healthcare Market, 2018 - 2030 (USD Million)
    • 6.6.2 Hospitals
      • 6.6.2.1 Hospitals Market, 2018 - 2030 (USD Million)
    • 6.6.3 Clinics
      • 6.6.3.1 Clinics Market, 2018 - 2030 (USD Million)
    • 6.6.4 Nurse Practitioners
      • 6.6.4.1 Nurse Practitioners Market, 2018 - 2030 (USD Million)
    • 6.6.5 Emt/ First Responders
      • 6.6.5.1 Emt/First Responders Market, 2018 - 2030 (USD Million)
    • 6.6.6 Veterinary
      • 6.6.6.1 Veterinary Market, 2018 - 2030 (USD Million)

Chapter 7 Stethoscope Market: Regional Market Analysis, By Technology Type, By Sale Channel, By End Use, 2018 - 2030 (USD Million, Units)

  • 7.1 Definition & Scope
  • 7.2 Regional Market Share Analysis, 2022 & 2030
  • 7.3 Regional Market Snapshot
  • 7.4 Market Size, & Forecasts, And Trend Analysis, 2022 & 2030
  • 7.5 North America
    • 7.5.1 North America Stethoscope Market, 2018 - 2030 (USD Million, Units)
    • 7.5.2 U.S.
      • 7.5.2.1 Key Country Dynamics
      • 7.5.2.2 Regulatory Structure & Reimbursement Framework
      • 7.5.2.3 Competitive Scenario
      • 7.5.2.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million, Units)
    • 7.5.3 Canada
      • 7.5.3.1 Key Country Dynamics
      • 7.5.3.2 Regulatory Structure & Reimbursement Framework
      • 7.5.3.3 Competitive Scenario
      • 7.5.3.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million, Units)
  • 7.6 Europe
    • 7.6.1 Europe Stethoscope Market, 2018 - 2030 (USD Million, Units )
    • 7.6.2 Uk
      • 7.6.2.1 Key Country Dynamics
      • 7.6.2.2 Regulatory Structure & Reimbursement Framework
      • 7.6.2.3 Competitive Scenario
      • 7.6.2.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million, Units)
    • 7.6.3 Germany
      • 7.6.3.1 Key Country Dynamics
      • 7.6.3.2 Regulatory Structure & Reimbursement Framework
      • 7.6.3.3 Competitive Scenario
      • 7.6.3.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million, Units)
    • 7.6.4 France
      • 7.6.4.1 Key Country Dynamics
      • 7.6.4.2 Regulatory Structure & Reimbursement Framework
      • 7.6.4.3 Competitive Scenario
      • 7.6.4.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million, Units)
    • 7.6.5 Italy
      • 7.6.5.1 Key Country Dynamics
      • 7.6.5.2 Regulatory Structure & Reimbursement Framework
      • 7.6.5.3 Competitive Scenario
      • 7.6.5.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million, Units)
    • 7.6.6 Spain
      • 7.6.6.1 Key Country Dynamics
      • 7.6.6.2 Regulatory Structure & Reimbursement Framework
      • 7.6.6.3 Competitive Scenario
      • 7.6.6.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million, Units)
    • 7.6.7 Denmark
      • 7.6.7.1 Key Country Dynamics
      • 7.6.7.2 Regulatory Structure & Reimbursement Framework
      • 7.6.7.3 Competitive Scenario
      • 7.6.7.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million, Units)
    • 7.6.8 Sweden
      • 7.6.8.1 Key Country Dynamics
      • 7.6.8.2 Regulatory Structure & Reimbursement Framework
      • 7.6.8.3 Competitive Scenario
      • 7.6.8.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million, Units)
    • 7.6.9 Norway
      • 7.6.9.1 Key Country Dynamics
      • 7.6.9.2 Regulatory Structure & Reimbursement Framework
      • 7.6.9.3 Competitive Scenario
      • 7.6.9.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million, Units)
  • 7.7 Asia Pacific
    • 7.7.1 Asia Pacific Stethoscope Market, 2018 - 2030 (USD Million, Units)
    • 7.7.2 Japan
      • 7.7.2.1 Key Country Dynamics
      • 7.7.2.2 Regulatory Structure & Reimbursement Framework
      • 7.7.2.3 Competitive Scenario
      • 7.7.2.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million, Units)
    • 7.7.3 China
      • 7.7.3.1 Key Country Dynamics
      • 7.7.3.2 Regulatory Structure & Reimbursement Framework
      • 7.7.3.3 Competitive Scenario
      • 7.7.3.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million, Units)
    • 7.7.4 India
      • 7.7.4.1 Key Country Dynamics
      • 7.7.4.2 Regulatory Structure & Reimbursement Framework
      • 7.7.4.3 Competitive Scenario
      • 7.7.4.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million, Units)
    • 7.7.5 South Korea
      • 7.7.5.1 Key Country Dynamics
      • 7.7.5.2 Regulatory Structure & Reimbursement Framework
      • 7.7.5.3 Competitive Scenario
      • 7.7.5.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million, Units)
    • 7.7.6 Australia
      • 7.7.6.1 Key Country Dynamics
      • 7.7.6.2 Regulatory Structure & Reimbursement Framework
      • 7.7.6.3 Competitive Scenario
      • 7.7.6.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million, Units)
    • 7.7.7 Thailand
      • 7.7.7.1 Key Country Dynamics
      • 7.7.7.2 Regulatory Structure & Reimbursement Framework
      • 7.7.7.3 Competitive Scenario
      • 7.7.7.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million, Units)
  • 7.8 Latin America
    • 7.8.1 Latin America Stethoscope Market, 2018 - 2030 (USD Million, Units )
    • 7.8.2 Brazil
      • 7.8.2.1 Key Country Dynamics
      • 7.8.2.2 Regulatory Structure & Reimbursement Framework
      • 7.8.2.3 Competitive Scenario
      • 7.8.2.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million, Units)
    • 7.8.3 Mexico
      • 7.8.3.1 Key Country Dynamics
      • 7.8.3.2 Regulatory Structure & Reimbursement Framework
      • 7.8.3.3 Competitive Scenario
      • 7.8.3.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million, Units)
    • 7.8.4 Argentina
      • 7.8.4.1 Key Country Dynamics
      • 7.8.4.2 Regulatory Structure & Reimbursement Framework
      • 7.8.4.3 Competitive Scenario
      • 7.8.4.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million, Units)
  • 7.9 MEA
    • 7.9.1 MEA Stethoscope Market, 2018 - 2030 (USD Million, Units )
    • 7.9.2 South Africa
      • 7.9.2.1 Key Country Dynamics
      • 7.9.2.2 Regulatory Structure & Reimbursement Framework
      • 7.9.2.3 Competitive Scenario
      • 7.9.2.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million, Units)
    • 7.9.3 Saudi Arabia
      • 7.9.3.1 Key Country Dynamics
      • 7.9.3.2 Regulatory Structure & Reimbursement Framework
      • 7.9.3.3 Competitive Scenario
      • 7.9.3.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million, Units)
    • 7.9.4 UAE
      • 7.9.4.1 Key Country Dynamics
      • 7.9.4.2 Regulatory Structure & Reimbursement Framework
      • 7.9.4.3 Competitive Scenario
      • 7.9.4.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million, Units)
    • 7.9.5 Kuwait
      • 7.9.5.1 Key Country Dynamics
      • 7.9.5.2 Regulatory Structure & Reimbursement Framework
      • 7.9.5.3 Competitive Scenario
      • 7.9.5.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million, Units)

Chapter 8 Stethoscope Market - Competitive Analysis

  • 8.1 Company Share Analysis, 2021
  • 8.2 Product/Brand Comparative Analysis
  • 8.3 List Of Key Distributors
    • 8.3.1 North America
    • 8.3.2 Europe
    • 8.3.3 Asia Pacific
    • 8.3.4 Latin America
    • 8.3.5 Middle East And Africa
  • 8.4 Company Profiles
    • 8.4.1 Eko Devices Inc.
      • 8.4.1.1 Company Overview
      • 8.4.1.2 Product Benchmarking
      • 8.4.1.3 Strategic Initiatives
    • 8.4.2 3m
      • 8.4.2.1 Company Overview
      • 8.4.2.2 Financial Performance
      • 8.4.2.3 Product Benchmarking
      • 8.4.2.4 Strategic Initiatives
    • 8.4.3 Medline Industries Inc.
      • 8.4.3.1 Company Overview
      • 8.4.3.2 Product Benchmarking
      • 8.4.2.3 Strategic Initiatives
    • 8.4.4 Heine Optotechnik Gmbh & Co. Kg
      • 8.4.4.1 Company Overview
      • 8.4.4.3 Product Benchmarking
    • 8.4.5 Welch Allyn (Hill-Rom Holdings, Inc.)
      • 8.4.5.1 Company Overview
      • 8.4.5.2 Financial Performance
      • 8.4.5.3 Product/Service Benchmarking
    • 8.4.6 Gf Health Products, Inc.
      • 8.4.6.1 Company Overview
      • 8.4.6.2 Product Benchmarking
      • 8.4.6.3 Strategic Initiatives
    • 8.4.7 Rudolf Riester Gmbh
      • 8.4.7.1 Company Overview
      • 8.4.7.2 Product Benchmarking
      • 8.4.7.3 Strategic Initiatives
    • 8.4.8 American Diagnostics Corporation
      • 8.4.8.1 Company Overview
      • 8.4.8.2 Financial Performance
      • 8.4.8.3 Product Benchmarking
      • 8.4.8.4 Strategic Initiatives
    • 8.4.9 Cardionics
      • 8.4.9.1 Company Overview
      • 8.4.9.2 Financial Performance
      • 8.4.9.3 Product Benchmarking
      • 8.4.9.4 Strategic Initiatives
    • 8.4.10 Heine Optotechnik Gmbh & Co. Kg
      • 8.4.10.1 Company Overview
      • 8.4.10.2 Financial Performance
      • 8.4.10.3 Product/Service Benchmarking
      • 8.4.10.4 Strategic Initiatives
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦